Boyle L, Kaufmann WE
Because human studies are limited, doctors do not yet have clear data on the peptide's long-term effects, optimal dosing, potential drug interactions, or safety across different patient populations
The Nrf2KEAP1 pathway stands as a master regulator of this balance, transcriptionally activating genes involved in GSH biosynthesis (GCLC, GCLM, GSR, and GSS), iron metabolism (FTL, FTH1, FPN1, and HO-1), and redox defense (SLC7A11, GPX4, and NQO1)all of which directly modulate ferroptosis susceptibility (283, 284)
doi: 10.1080/1744666X.2019.1705785
When semaglutide binds to GLP-1 receptors located in your pancreas, brain, and gastrointestinal tract, it stimulates glucose-dependent release of insulin and decreases glucagon secretion
doi: 10.1007/s12264-012-1273-z 141 XieT.BelinskyM.XuY.JaiswalA